Evolution of the Average Target: Cardiol Therapeutics Inc.

Evolution of the Target Price: Cardiol Therapeutics Inc.

Changes in Analyst Recommendations: Cardiol Therapeutics Inc.

5600e606.p-_-g7GhH4MUsHSxLIgk8RSqRbWKV1YrK2ZTokamV3g.6LmJ9IPNZ_RWhCT1YcBLi3nzdvzLOyEeW1Qy7X7rGknEibS785Ja0mTcBw~25d8090be04355bec77362b59faada9f

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+298.67%
+33.05%
+14.91%
+52.64%
+34.39%
+49.16%
-3.63%
+13.38%
+41.54%
Average +59.35%
Weighted average by Cap. +32.04%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.505CAD
Average target price
6.000CAD
Spread / Average Target
+298.67%
High Price Target
7.000CAD
Spread / Highest target
+365.12%
Low Price Target
5.000CAD
Spread / Lowest Target
+232.23%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Canaccord Genuity
HC Wainwright
Cantor Fitzgerald
Raymond James
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.505CAD
Average target price
6.000CAD
Spread / Average Target
+298.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CRDL Stock
  4. Consensus Cardiol Therapeutics Inc.
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!